Characterization of viability and proliferation of alginate-poly-L-lysine- alginate encapsulated myoblasts using flow cytometry

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 94, Issue 2, 2010, Pages 296-304

  Thakur, Ajit ^a   Sengupta, Ruchira ^a   Matsui, Hideto ^b   Lillicrap, David ^b   Jones, Kim ^a   Hortelano, Gonzalo ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c CANADIAN BLOOD SERVICES   (Canada)

Author keywords

Alginate poly L lysine alginate; Gene therapy; Granularity; Myoblasts; Proliferation; Viability

Indexed keywords

ALGINATE; AMINO ACIDS; CELL PROLIFERATION; ENCAPSULATION; FLOW CYTOMETRY; GENE THERAPY; GENETIC ENGINEERING;

CELL THERAPY; COMPREHENSIVE EXAMINATION; CYTOMETRY; ENCAPSULATED CELL; FLOW CYTOMETRY ANALYSIS; FREE CELLS; GENETICALLY MODIFIED; GRANULAR CELLS; GRANULARITY; IN-VITRO; IN-VIVO; L-LYSINE; MICROCAPSULES; MYOBLASTS; NOVEL METHODS; ON FLOW; POLY-L-LYSINE; THERAPEUTIC PRODUCTS;

CELL CULTURE;

ALGINIC ACID; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; CALCEIN; CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD86 ANTIGEN; POLYLYSINE; TRYPAN BLUE; ALGINATE POLYLYSINE ALGINATE; ARTIFICIAL MEMBRANE; MICROCAPSULE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL BASED GENE THERAPY; CELL CULTURE; CELL ENCAPSULATION; CELL PROLIFERATION; CELL SECRETION; CELL STRAIN; CELL STRAIN G 8; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSDUCTION; GRANULAR CELL; IN VITRO STUDY; IN VIVO STUDY; MICROENCAPSULATION; MOUSE; MYOBLAST; NONHUMAN; PROCEDURES CONCERNING CELLS; TRYPAN BLUE EXCLUSION; ANALOGS AND DERIVATIVES; ANIMAL; ARTIFICIAL MEMBRANE; CELL SURVIVAL; CELL TRANSPLANTATION; CHEMISTRY; CYTOLOGY; DOG; DRUG DELIVERY SYSTEM; DRUG EFFECTS; GENETIC TRANSFECTION; METABOLISM; MICROCAPSULE; PROCEDURES; SECRETION (PROCESS);

ALGINATES; ANIMALS; CAPSULES; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; DOGS; DRUG DELIVERY SYSTEMS; FACTOR VIII; FLOW CYTOMETRY; MEMBRANES, ARTIFICIAL; MICE; MYOBLASTS; POLYLYSINE; TRANSFECTION;

EID: 77955360629     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31648     Document Type: Article

References (36)

1. Orive G, Tam SK, Pedraz JL, Halle JP. Biocompatibility of alginate-poly-L-lysine microcapsules for cell therapy. Biomaterials 2006;27:3691-700. (Pubitemid 43670522)
2. Chang T. Therapeutic applications of polymeric artificial cells. Nat Rev Drug Discov 2005;4:221-235. (Pubitemid 40372556)
3. Kashani SA, Chang T. Effects of hepatic stimulatory factor released from free or microencapsulated hepatocytes on galactosamine induced fulminant hepatic failure animal model. Biomater Artif Cells Immobilization Biotechnol 1991;19:565-577.
4. Wong H, Chang T. The viability and regeneration of artificial cell microencapsulated rat hepatocyte xenograft transplants in mice. Biomater Artif Cells Artif Organs 1988;16:731-739.
5. Ponce S, Orive G, Hernandez R, Gascon AR, Pedraz JL, De Haan BJ, Faas MM, Mathieu HJ, De Vos P. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials 2006;27:4831-4839. (Pubitemid 43884839)
6. Garcia-Martin C, Chuah MK, Van Damme A, Robinson KE, Vanzieleghem B, Saint-Remy JM, Gallardo D, Ofosu FA, Vandendriessche T, Hortelano G. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells: Potential for gene therapy of haemophilia A. J Gene Med 2002;4:215-223. (Pubitemid 40277171)
7. Hortelano G, Al-Hendy A, Ofosu FA, Chang PL. Delivery of human factor IX in mice by encapsulated recombinant myoblasts: A novel approach towards allogeneic gene therapy of hemophilia B. Blood 1996;87:5095-5103. (Pubitemid 26189850)
8. Hortelano G, Wang L, Xu N, Ofosu FA. Sustained and therapeutic delivery of factor IX in nude haemophilia B mice by encapsulated C2C12 myoblasts: Concurrent tumourigenesis. Haemophilia 2001; 7:207-214. (Pubitemid 32243804)
9. Hortelano G, Xu N, Vandenberg A, Solera J, Chang PL, Ofosu FA. Persistent delivery of factor IX in mice: Gene therapy for hemophilia using implantable microcapsules. Hum Gene Ther 1999;10: 1281-1288. (Pubitemid 29267583)
10. Wen J, Vargas AG, Ofosu FA, Hortelano G. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: Key role of encapsulated cells. J Gene Med 2006;8:362-369.
11. Wen J, Xu N, Li A, Bourgeois J, Ofosu FA, Hortelano G. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice. J Gene Med 2007;9:1002-1010. (Pubitemid 350104415)
12. Wehn T, Lorenz T, Behrendt U, Wallerius C, Bontemeyer H, Lehmann J. Determination of animal cell densities and viabilities by the new analyzer CEDX2. Animal cell technology: Products from cells, cells as products. In: Proceedings of the 16th ESACT Meeting, Bielefeld. 1999, p 634.
13. Jones KH, Senft JA. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. J Histochem Cytochem 1985;33:77-79.
14. Altman SA, Randers L, Rao G. Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations. Biotechnol Prog 1993;9:671-674. (Pubitemid 2022153)
15. Loken M. Immunofluorescence Techniques in Flow Cytometry and Sorting. New York: Wiley; 1990.
16. Sandhu KS, Naciri M, Al-Rubeai M. Prediction of recombinant protein production in an insect cell-baculovirus system using a flow cytometric technique. J Immunol Methods 2007;325:104-113. (Pubitemid 47238293)
17. Bez A, Corsini E, Curti D, Biggiogera M, Colombo A, Nicosia RF, Pagano SF, Parati E. Neurosphere and neurosphere-forming cells: Morphological and ultrastructural characterization. Brain Res 2003;993:18-29. (Pubitemid 37464579)
18. Murayama A, Matsuzaki Y, Kawaguchi A, Shimazaki T, Okano H. Flow cytometric analysis of neural stem cells in the developing and adult mouse. Brain 2002;69:837-847. (Pubitemid 34984701)
19. Nordström T, Willamo P, Arvela M, Stenroos K, Lindqvist C. Detection of baculovirus-infected insect cells by flow cytometric side-scatter analyses. Cytometry 1999;37:238-242. (Pubitemid 29504091)
20. Blau HM, Dhawan J, Pavlath GK. Myoblasts in pattern formation and gene therapy. Trends Genet 1993;9:269-274.
21. Blau HM, Webster C. Isolation and characterization of human muscle cells. Proc Natl Acad Sci USA 1981;78:5623-5627.
22. Hawkins ED, Hommel M, Turner ML, Battye FL, Markham JF, Hodgkin PD. Measuring lymphocyte proliferation, survival and differentiation using CFSE time-series data. Nat Protoc 2007;2:2057-2067.
23. Matsui H, Shibata M, Brown B, Labelle A, Hegadorn C, Andrews C, Hebbel RP, Galipeau J, Hough C, Lillicrap D. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors. Stem Cells 2007;25:2660-2669.
24. De Groot M, Leuvenink HG, Keizer PP, Fekken S, Schuurs TA, Van Schilfgaarde R. Effective removal of alginate-poly-L-lysine microcapsules from pancreatic islets by use of trypsin-EDTA. J Biomed Mater Res A 2003;67:679-683.
25. Spence DJ, Peyman GA. A new technique for the vital staining of the corneal endothelium. Invest Ophthalmol 1976;15:1000-1002.
26. Possee RD, Mccarroll L, Thomas CJ, Mann SG, King L. Baculovirus expression vectors: Improving virus-infected cell viability and recombinant protein secretion. In: Al-Rubeai M, editor. Cell Engineering. Netherlands: Springer; 1999. pp 108-121.
27. De Vos P, Van Hoogmoed CG, De Haan BJ, Busscher H. Tissue responses against immunoisolating alginate-PLL capsules in the immediate post-transplant period. J Biomed Mater Res 2002;62: 430-437.
28. Malhotra JD, Miao H, Zhang K, Wolfson A, Pennathur S, Pipe SW, Kaufman R. Antioxidants reduce endoplasmic reticulum stress and improve protein secretion. Proc Natl Acad Sci USA 2008;105: 18525-18530.
29. Srour MA, Grupp J, Aburubaiha Z, Albert T, Brondke H, Oldenburg J, Schwaab R. Modified expression of coagulation factor VIII by addition of a glycosylation site at the N terminus of the protein. Ann Hematol 2008;87:107-112.
30. Kaufman RJ, Pipe SW, Tagliavacca L, Swaroop M, Moussalli M. Biosynthesis, assembly and secretion of coagulation factor VIII. Blood Coagul Fibrinolysis 1997;8:S3-S14.
31. De Guzman RC, Ereifej ES, Broadrick KM, Rogers RA, Vandevord P. Alginate-matrigel microencapsulated Schwann cells for inducible secretion of glial cell line derived neurotrophic factor. J Microencapsulation 2008;25:487-498.
32. Lansdown AB, Payne M. An evaluation of the local reaction and biodegradation of calcium sodium alginate (Kaltostat) following subcutaneous implantation in the rat. J R Coll Surg Edinb 1994; 39:284-288.
33. Augst AD, Kong HJ, Mooney D. Alginate hydrogels as biomaterials. Macromol Biosci 2006;6:623-633.
34. Nakanishi K, Dohmae N, Morishima N. Endoplasmic reticulum stress increases myofiber formation in vitro. FASEB J 2007;21: 2994-3003.
35. Hawke TJ, Garry D. Myogenic satellite cells: Physiology to molecular biology. J Appl Physiol 2001;91:534-551.
36. Sitton G, Hansgate A, Srienc F. Transient gene expression in CHO cells monitored with automated flow cytometry. Cytotechnology 2006;52:13-24.